HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Sub-New Stocks

356.083

+2.7240.77%

Number of Gainers:35

Number of Losers:11

Number of Flat:13

PE:- -

High:359.701

Open:353.321

Low:353.104

Close:353.359

Volume:94.13M

Turnover:2.64B

Market Cap:850.24B

Float Cap:736.34B

Loading ...

Keymed Biosciences Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Simply Wall St.

Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook

Betterlife Holding Expects HY Loss of up to RMB 105 Million

Massive Recall of Over 4 Million Vehicles Addresses Door Handle Safety Flaw That Could Hinder Emergency Escape

Linklogis (SEHK:9959) Stock Rebounds As Profit Returns But Valuation Stays Rich

Simply Wall St.

China General Education Group Files Board, Committee Member List with Disclosure Responsibilities

BetterLife Expects H1 Loss Attributable to Owners up to RMB 105 Million

BetterLife Holding - Expects Loss of up to Rmb105 Mln for Six Months Ended June 30, 2026

THOMSON REUTERS

BetterLife Holding - Expected Hy Profit Decrease Mainly Due to Lower Automobile Sales and Weak Market Sentiment

THOMSON REUTERS

Biotech Firm Antengene's H1 Revenue Jumps on Licensing Deals

China's Jinxin Fertility Group Interim Revenue Rises on U.S. IVF Demand

Citi Raises Keymed Bio's Target Price to HK$97.5, Maintains Buy/High-Risk Rating

Norway's Medistim Q2 Revenue Rises on Own-Product Sales Growth

Hong Kong Stock Market Flash: BRII-B Surges Over 8% as Interim Loss Narrows 32.08% and Promising Clinical Data Emerges

ZYLOXTB Surges Over 9% Intraday on Strong H1 Net Profit of 179 Million Yuan, Up 47.8% Year-On-Year

China's Brii Biosciences Interim Net Loss Narrows on Lower R&D Expenses

Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

THOMSON REUTERS

Brii Biosciences: Hy Other Income Rmb19.5 Mln

THOMSON REUTERS

Brii Bio H1 FY26 Loss Narrows 32.1% to RMB 101 Million

Keymed Biosciences (SEHK:2162) Stock Questions Whether New Profit Can Last

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK1587/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1587","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","market":"HK","secType":"PLATE","nameCN":"Sub-New Stocks","latestPrice":356.08286,"timestamp":1787299686774,"preClose":353.3587,"halted":0,"volume":94134864,"delay":0,"changeRate":0.007709,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":2.724152,"latestTime":"08-21 16:00:00","open":353.32068,"high":359.70123,"low":353.1036,"amount":2637729260,"amplitude":0.018671,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"pbRate":1.489153,"peRate":15.43782,"turnoverRate":0.001915,"increases":37,"decrements":11,"flats":10,"marketCap":850239932904,"floatMarketCap":736343976584},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1587\",,,,,undefined,":{"symbol":"BK1587","high":359.70123,"amplitude":0.018671,"preClose":353.3587,"low":353.1036,"pbRate":"1.489153","latestPrice":356.08286,"volume":94134864,"delay":0,"open":353.32068,"prevYearClose":478.5753,"prevWeekClose":346.279,"prevMonthClose":368.648,"prevQuarterClose":326.657,"fiveDayClose":346.279,"twentyDayClose":349.449,"sixtyDayClose":381.872,"secType":"PLATE","market":"HK","turnoverRate":0.001915,"peRate":15.43782,"marketCap":850239932904,"floatMarketCap":736343976584,"timestamp":1787299686774,"nameCN":"Sub-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1587\",,,,undefined,":{"bkCode":"BK1587","up":35,"down":11,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1587\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661215890","title":"Keymed Biosciences Inc. Just Missed Earnings - But Analysts Have Updated Their Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2661215890","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661215890?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:01","pubTimestamp":1787353294,"startTime":"0","endTime":"0","summary":"Investors in Keymed Biosciences Inc. ( HKG:2162 ) had a good week, as its shares rose 2.8% to close at HK$80.30...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/keymed-biosciences-inc-just-missed-earnings-but-analysts-hav","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/keymed-biosciences-inc-just-missed-earnings-but-analysts-hav","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1587","GXDW","JOYT","02162","VGFPF","FEBU","PMDE","BK1574","RGLO","VOTE","DECU","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661901362","title":"Niki BioSolutions Weighs Financing Options as Going-Concern Warning Clouds Post-Merger Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2661901362","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661901362?lang=en_us&edition=fundamental","pubTime":"2026-08-22 05:15","pubTimestamp":1787346928,"startTime":"0","endTime":"0","summary":"Niki BioSolutionsweighs financing options as going-concern warning clouds post-merger outlookOverviewUS biopharmaceutical developer's H1 net loss widened, with loss per share at $1.6Operating expenses","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0TG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06996","IE00BZ08YT58.USD","BK1574","BK1191","02137","BK1587","01177","BK1589","BK4139","IE00BZ08YR35.GBP","BK1515","IE00BZ08YS42.EUR","BK1521","BK1583","HK0000165453.HKD","NIKI","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661915072","title":"Betterlife Holding Expects HY Loss of up to RMB 105 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661915072","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661915072?lang=en_us&edition=fundamental","pubTime":"2026-08-21 23:58","pubTimestamp":1787327937,"startTime":"0","endTime":"0","summary":"Aug 21 (Reuters) - BetterLife Holding Ltd <6909.HK>::*EXPECTS LOSS OF UP TO RMB105 MILLION FOR SIX MONTHS ENDED JUNE 30, 2026*EXPECTED HY PROFIT DECREASE MAINLY DUE TO LOWER AUTOMOBILE SALES AND WEAK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nRSD79HJbK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","06909","BK1520","BK1239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130205206","title":"Massive Recall of Over 4 Million Vehicles Addresses Door Handle Safety Flaw That Could Hinder Emergency Escape","url":"https://stock-news.laohu8.com/highlight/detail?id=1130205206","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130205206?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:43","pubTimestamp":1787319805,"startTime":"0","endTime":"0","summary":"On August 21, nine automakers simultaneously announced recalls for multiple vehicle models due to a door handle defect. The companies involved include FAW Group, BAIC BluePark, Dongfeng Motor, Chery,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLO","LU2087621335.USD","BK4511","LU0964807845.USD","STSLAmain","LU1066051225.USD","LU1429558221.USD","LU0109391861.USD","BK4551","BK4592","LU1720051017.SGD","LU1548497426.USD","LU1066051811.HKD","LU0234572021.USD","SG9999015986.USD","LU0320765059.SGD","LU2417539215.USD","IE00BSNM7G36.USD","LU2250418816.HKD","LU0820561909.HKD","LU2471134796.USD","IE00B19Z8X17.USD","LU2168564149.EUR","TSLI","ELOL","LU2602419157.SGD","SG9999015978.USD","07766","BK4534","BK1610","LU0820562030.AUD","LU2420271590.USD","LU0082616367.USD","LU2213496289.HKD","HK0000914660.USD","LU0234570918.USD","LU2023250330.USD","LU0133085943.USD","LU1839511570.USD","LU0345770308.USD","LU0198837287.USD","IE00B1XK9C88.USD","TSL","LU2462157665.USD","LU1861220033.SGD","TSLW","TSLZ","BK4588","WATS","LU1267930730.SGD","TSLP","LU2471134952.CNY","BK4581","TEST","TSLA","SG9999015945.SGD","SMOG","LU0466842654.USD","LU1861559042.SGD","TESC","XPEV","TSDD","LU1066053197.SGD","LIT","LU1232071149.USD","TSLG","LU1629891620.HKD","LU0053666078.USD","BK1119","TSLR","LU0323591593.USD","LU1674673691.USD","LU1861558580.USD","LU0708995401.HKD","LU1145028129.USD","LU2290526834.HKD","LU1366192091.USD","IE00BJLML261.HKD","LU1778281490.HKD","BK4574","LU2108987350.USD","LU0097036916.USD","LU2360106780.USD","BK4550","LU0345770993.USD","BK4533","BK4585","LU1551013425.SGD","LU0823414478.USD","BK1588","IE0034235303.USD","IE00B19Z8W00.USD","LU1674673428.USD","BK1587","LU2168563687.JPY","TSII","LU1066051498.USD","IE00BK4W5L77.USD","LU2063271972.USD","TESL","LU1435385759.SGD","LU2360107168.USD","TSLY","09366","LU0689472784.USD","LU0593848301.USD","LU0823411888.USD","LU2357305700.SGD","IDRV","TSLL","LU2168564222.USD","LU2326559502.SGD","LU0348723411.USD","LU2756315664.SGD","LU2896262040.SGD","TSYY","09766","BK4555","BK1575","LU2249611893.SGD","LU0820561818.USD","LU2168564495.EUR","IE00BWXC8680.SGD","BK4099","BK4548","LU0077335932.USD","LU2236285917.USD","HK0000914686.HKD","TSLQ","LU1914381329.SGD","CRSH","LU0719512351.SGD","LU1720051108.HKD","LU2750360641.GBP","LU0345769128.USD","LU0943347566.SGD","LU2750360997.AUD","LU2403377893.USD","LU0056508442.USD","BK4612","TLA","FDRV","SG9999015952.SGD","TSLT","LU1852331112.SGD","IE00B1BXHZ80.USD","LU0210536198.USD","IE00B19Z9505.USD","LU2168564065.EUR","LU2456880835.USD","LU2756315318.SGD","LU1861215975.USD","09868","BK4516","LU0345769631.USD","BK1539","BK4598","LU1551013342.USD","LU0316494557.USD","WANT","BK4604","BK4527","LU2471134879.HKD","LU2471134523.USD","07366","LU0672654240.SGD","IE00BK4W5M84.HKD","TSLS","BK4543"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661029511","title":"Linklogis (SEHK:9959) Stock Rebounds As Profit Returns But Valuation Stays Rich","url":"https://stock-news.laohu8.com/highlight/detail?id=2661029511","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661029511?lang=en_us&edition=fundamental","pubTime":"2026-08-21 21:22","pubTimestamp":1787318555,"startTime":"0","endTime":"0","summary":"Linklogis walked into this earnings day with the stock up 15% over the past month, trading at HK$2.30 and priced as a growth story in Hong Kong fintech. The market has been paying a premium P/S multiple for that story. The headline from H1 2026 is simple. The company moved back to a small profit, with basic earnings per share of CNY0.01 and net income of CNY23.936m, after a series of losses. For a stock built on future promises, this shift toward profitability is what matters most right...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/software/hkg-9959/linklogis-shares/news/linklogis-sehk9959-stock-rebounds-as-profit-returns-but-valu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/software/hkg-9959/linklogis-shares/news/linklogis-sehk9959-stock-rebounds-as-profit-returns-but-valu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1109","09959","BK1518","BK1619","BK1587","BK1575","BK1516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217298","title":"China General Education Group Files Board, Committee Member List with Disclosure Responsibilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217298","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661217298?lang=en_us&edition=fundamental","pubTime":"2026-08-21 20:51","pubTimestamp":1787316689,"startTime":"0","endTime":"0","summary":"China General Education Group files board, committee member list with disclosure responsibilitiesChina General Education Group updated its board and committee roster dated Aug. 10, 2026.Board led by C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL4gvLzb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02175","BK1556","BK1587","BK1228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661126294","title":"BetterLife Expects H1 Loss Attributable to Owners up to RMB 105 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661126294","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661126294?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:54","pubTimestamp":1787309688,"startTime":"0","endTime":"0","summary":"BetterLife expects H1 loss attributable to owners up to RMB 105 millionBetterLife flagged a first-half loss attributable to owners of up to RMB 105 million, reversing a RMB 7.1 million profit.Weaker a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL6w9zKd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1239","BK1587","06909","BK1520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661262915","title":"BetterLife Holding - Expects Loss of up to Rmb105 Mln for Six Months Ended June 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2661262915","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661262915?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:54","pubTimestamp":1787309683,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0JZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","06909","BK1520","BK1239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661226299","title":"BetterLife Holding - Expected Hy Profit Decrease Mainly Due to Lower Automobile Sales and Weak Market Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2661226299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661226299?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:54","pubTimestamp":1787309683,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nFWN44I0JZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","06909","BK1239","BK1520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661264711","title":"Biotech Firm Antengene's H1 Revenue Jumps on Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264711","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264711?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:38","pubTimestamp":1787308735,"startTime":"0","endTime":"0","summary":"Biotech firm Antengene's H1 revenue jumps on licensing dealsOverviewBiotech company's H1 revenue rose sharply on licensing deals with UCB, K2 TherapeuticsCompany swung to H1 net profit from loss a yea","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0AK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1191","BK1587","06996","06855","BK1574","BK1161","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661264564","title":"China's Jinxin Fertility Group Interim Revenue Rises on U.S. IVF Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2661264564","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661264564?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:23","pubTimestamp":1787307829,"startTime":"0","endTime":"0","summary":"China's Jinxin Fertility Group interim revenue rises on U.S. IVF demandOverviewChina fertility clinic operator's interim revenue for six months to June 30 grew 6.6% yr/yrNet profit for the six months ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I0A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","BK1597","BK1583","01951","BK1587","BK1100","02190","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162184322","title":"Citi Raises Keymed Bio's Target Price to HK$97.5, Maintains Buy/High-Risk Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1162184322","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162184322?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:54","pubTimestamp":1787298869,"startTime":"0","endTime":"0","summary":"Citi has released a research report highlighting that KEYMED BIO-B (02162) posted first-half 2026 revenue of RMB617 million, marking a 24% year-over-year increase. Notably, sales of stapokibart...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1074936037.SGD","LU1366192091.USD","LU0098860793.USD","LU0170899867.USD","LU0162691827.USD","LU0477156953.USD","LU0320765646.SGD","LU0106831901.USD","BK4207","LU2125154778.USD","EWH","LU1201861249.SGD","LU2462157665.USD","LU1162221912.USD","LU1244550221.USD","LU1791807156.HKD","LU1267930227.SGD","LU0648001328.SGD","LU2417539215.USD","LU0128525689.USD","LU0314106906.USD","LU1144417596.USD","BK1161","02162","LU1668664300.SGD","LU2236285917.USD","BK4566","LU0130517989.USD","LU1244550494.USD","LU0203347892.USD","LU0130102774.USD","LU0052756011.USD","LU2456880835.USD","IE00BSNM7G36.USD","C","IYF","BK1583","FTXO","LU2125154935.USD","BK1574","LU2360032135.SGD","BK4504","LU0203345920.USD","TFNS","BK1587","LU1244550577.SGD","BK4534","LU0980610538.SGD","LU0072461881.USD","LU1506573853.SGD","BK4559","LU0310800965.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661825746","title":"Norway's Medistim Q2 Revenue Rises on Own-Product Sales Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2661825746","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661825746?lang=en_us&edition=fundamental","pubTime":"2026-08-21 14:40","pubTimestamp":1787294458,"startTime":"0","endTime":"0","summary":"Norway's Medistim Q2 revenue rises on own-product sales growthOverviewNorway medical device maker's Q2 revenue grew 19.5% yr/yr to NOK 202 mlnQ2 operating profit (EBIT) rose 20.6% to NOK 65.3 mln, EBI","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL1N44I05U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1574","02190","BK1583","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179632017","title":"Hong Kong Stock Market Flash: BRII-B Surges Over 8% as Interim Loss Narrows 32.08% and Promising Clinical Data Emerges","url":"https://stock-news.laohu8.com/highlight/detail?id=1179632017","media":"Stock News","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179632017?lang=en_us&edition=fundamental","pubTime":"2026-08-21 11:41","pubTimestamp":1787283672,"startTime":"0","endTime":"0","summary":"Shares of BRII-B (02137) climbed more than 8% before the midday break, trading up 8.16% at HK$1.06 with turnover reaching HK$52.37 million.The company released its interim results for the six months...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","VXUS","KCAI","BK1574","BK4585","02137","BK1161","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108482719","title":"ZYLOXTB Surges Over 9% Intraday on Strong H1 Net Profit of 179 Million Yuan, Up 47.8% Year-On-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1108482719","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108482719?lang=en_us&edition=fundamental","pubTime":"2026-08-21 10:10","pubTimestamp":1787278248,"startTime":"0","endTime":"0","summary":"ZYLOXTB (02190) saw its shares climb more than 9% following the release of its interim results, before settling to a gain of 5.48% at 20.78 Hong Kong dollars, with turnover reaching 21.85 million...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","BK1100","BK1583","02190"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661125866","title":"China's Brii Biosciences Interim Net Loss Narrows on Lower R&D Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2661125866","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661125866?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:14","pubTimestamp":1787267641,"startTime":"0","endTime":"0","summary":"China's Brii Biosciences interim net loss narrows on lower R&D expensesOverviewChina biotech firm's interim net loss narrowed for six months ended June 30, 2026Lower R&D and administrative expenses co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL1N44H13O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02137","BK1161","06855","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661638258","title":"Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2661638258","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661638258?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:10","pubTimestamp":1787267400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUABLCVSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","02137","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661325830","title":"Brii Biosciences: Hy Other Income Rmb19.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2661325830","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661325830?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:02","pubTimestamp":1787266922,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nPLXMQ7KNH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1587","BK1574","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258376","title":"Brii Bio H1 FY26 Loss Narrows 32.1% to RMB 101 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258376","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258376?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:01","pubTimestamp":1787266863,"startTime":"0","endTime":"0","summary":"Brii Bio H1 FY26 loss narrows 32.1% to RMB 101 millionBrii Bio posted an IFRS net loss of RMB 101 million, narrowing 32.1% from a year earlier; basic loss per share improved to RMB 0.14.Other income f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL4prdW4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1161","BK1574","02137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661303292","title":"Keymed Biosciences (SEHK:2162) Stock Questions Whether New Profit Can Last","url":"https://stock-news.laohu8.com/highlight/detail?id=2661303292","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661303292?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:33","pubTimestamp":1787257986,"startTime":"0","endTime":"0","summary":"Keymed Biosciences stock has cooled in recent weeks, with the share price down about 10.6% over the past month even after moving into the black over the last year. Today's earnings story is all about profit, not hype. Basic earnings per share for the first half of 2026 came in at ¥4.29, flipping from losses in 2025, and trailing twelve month earnings now support a P/E of 25.4x.\nThe market is treating that P/E as a question mark. The key issue now is whether investors see this new...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/keymed-biosciences-sehk2162-stock-questions-whether-new-prof","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2162/keymed-biosciences-shares/news/keymed-biosciences-sehk2162-stock-questions-whether-new-prof","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1583","DECU","FEBU","RGLO","VOTE","GXDW","BK1587","VGFPF","PMDE","BK1574","02162","JOYT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":194,"code":"91000000","status":"200"}]}}